Clinical trials
Phase 2 Urinary Bladder Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| National Cancer Center, Korea | 2 |
| Asan Medical Center | 1 |
| Astellas Pharma Inc | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| BicycleTx Limited | 1 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 21 |
| Ovarian Neoplasms | 5 |
| Pancreatic Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Transitional Cell | 4 |
| Esophageal Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Cholangiocarcinoma | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.